These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33190085)

  • 1. Patient experiences of as-needed budesonide-formoterol by Turbuhaler® for treatment of mild asthma; a qualitative study.
    Foster JM; Beasley R; Braithwaite I; Harrison T; Holliday M; Pavord I; Reddel HK
    Respir Med; 2020 Dec; 175():106154. PubMed ID: 33190085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial.
    Hardy J; Baggott C; Fingleton J; Reddel HK; Hancox RJ; Harwood M; Corin A; Sparks J; Hall D; Sabbagh D; Mane S; Vohlidkova A; Martindale J; Williams M; Shirtcliffe P; Holliday M; Weatherall M; Beasley R;
    Lancet; 2019 Sep; 394(10202):919-928. PubMed ID: 31451207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives of mild asthma patients on maintenance versus as-needed preventer treatment regimens: a qualitative study.
    Foster J; Beasley R; Braithwaite I; Harrison T; Holliday M; Pavord I; Reddel H
    BMJ Open; 2022 Jan; 12(1):e048537. PubMed ID: 35063953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination budesonide/formoterol inhaler as sole reliever therapy in Māori and Pacific people with mild and moderate asthma.
    Hardy J; Tewhaiti-Smith J; Baggott C; Fingleton J; Semprini A; Holliday M; Hancox RJ; Weatherall M; Harwood M
    N Z Med J; 2020 Aug; 133(1520):61-72. PubMed ID: 32994594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Tolerability of High-Dose Budesonide/Formoterol via Turbuhaler® in Japanese Patients with Asthma : A Randomized, Double-Blind, Crossover, Active Comparator-Controlled, Phase III Study.
    Saito T; Hasunuma T
    Clin Drug Investig; 2012 Jan; 32(1):51-61. PubMed ID: 27933599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UK.
    FitzGerald JM; Arnetorp S; Smare C; Gibson D; Coulton K; Hounsell K; Golam S; Sadatsafavi M
    Respir Med; 2020 Sep; 171():106079. PubMed ID: 32917353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blinded, double-dummy efficacy and safety study of budesonide-formoterol Spiromax® compared to budesonide-formoterol Turbuhaler® in adults and adolescents with persistent asthma.
    Virchow JC; Rodriguez-Roisin R; Papi A; Shah TP; Gopalan G
    BMC Pulm Med; 2016 Mar; 16():42. PubMed ID: 26987997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol Turbuhaler
    Syk J; Vinge I; Sörberg M; Vahteristo M; Rytilä P
    Adv Ther; 2019 Jul; 36(7):1756-1769. PubMed ID: 30941722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma.
    Beasley R; Holliday M; Reddel HK; Braithwaite I; Ebmeier S; Hancox RJ; Harrison T; Houghton C; Oldfield K; Papi A; Pavord ID; Williams M; Weatherall M;
    N Engl J Med; 2019 May; 380(21):2020-2030. PubMed ID: 31112386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trial.
    Pilcher J; Patel M; Pritchard A; Thayabaran D; Ebmeier S; Shaw D; Black P; Braithwaite I; Weatherall M; Beasley R
    NPJ Prim Care Respir Med; 2017 May; 27(1):33. PubMed ID: 28496190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild Asthma.
    Bateman ED; Reddel HK; O'Byrne PM; Barnes PJ; Zhong N; Keen C; Jorup C; Lamarca R; Siwek-Posluszna A; FitzGerald JM
    N Engl J Med; 2018 May; 378(20):1877-1887. PubMed ID: 29768147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma.
    Lalloo UG; Malolepszy J; Kozma D; Krofta K; Ankerst J; Johansen B; Thomson NC
    Chest; 2003 May; 123(5):1480-7. PubMed ID: 12740264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given 'as needed' in mild asthma: study protocols for two randomised controlled trials.
    O'Byrne PM; FitzGerald JM; Zhong N; Bateman E; Barnes PJ; Keen C; Almqvist G; Pemberton K; Jorup C; Ivanov S; Reddel HK
    Trials; 2017 Jan; 18(1):12. PubMed ID: 28069068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial.
    Rabe KF; Pizzichini E; Ställberg B; Romero S; Balanzat AM; Atienza T; Lier PA; Jorup C
    Chest; 2006 Feb; 129(2):246-256. PubMed ID: 16478838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equivalent bronchodilation with budesonide/formoterol combination via Easyhaler and Turbuhaler in patients with asthma.
    Lähelmä S; Vahteristo M; Metev H; Taseva M; Stamatova N; Bartha A; Schlezák J; Sairanen U
    Respir Med; 2016 Nov; 120():31-35. PubMed ID: 27817813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
    Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L
    Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Budesonide/formoterol maintenance and reliever therapy versus conventional best standard treatment in asthma in an attempted 'real life' setting.
    Søes-Petersen U; Kava T; Dahle R; Lei Y; Dam N
    Clin Respir J; 2011 Jul; 5(3):173-82. PubMed ID: 21679353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symbicort: controlling asthma in adults.
    Lalloo U
    Respir Med; 2002 Feb; 96 Suppl A():S16-22. PubMed ID: 11858561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and tolerability of high-dose budesonide/formoterol via Turbuhaler® in Japanese patients with asthma: a randomized, double-blind, crossover, active comparator-controlled, phase III study.
    Saito T; Hasunuma T
    Clin Drug Investig; 2012 Jan; 32(1):51-61. PubMed ID: 22024920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canadian economic evaluation of budesonide-formoterol as maintenance and reliever treatment in patients with moderate to severe asthma.
    Miller E; Sears MR; McIvor A; Liovas A
    Can Respir J; 2007; 14(5):269-75. PubMed ID: 17703241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.